SPUTNIK Vaccine for COVID 19 (corona virus)

SPUTNIK Vaccine

1. SPUTNIK V

2. World’s first vaccine based on a well studied human adenovirus vector platform. Vaccine’s efficacy is 97.6 % Developed by Gamaleya Research Institute of Epidemiology and Microbilogy in Russia .

3. Route of administration - Intramuscular Stored at 2 - 8 °C Freeze-dried powder must be reconstituted with sterile water before use. First dose is to be administered on the first day Second dose is administered on 21st day to boost immune response . Both doses are administered into the deltoid muscle.

4. SPUTNIK V LIGHT Single dose vaccine consisting of only the first dose of Sputnik V Intended for areas with acute outbreaks Will be used as a third (booster) dose for those who have received Sputnik V at least 6 months earlier. Developed on August 11,2021

5. INCOVACC Intranasal vaccine stimulates a broad immune response - neutralizing IgG, mucosal IgA, and T cell responses. Immune responses at the site of infection ( in the nasal mucosa ) - essential for blocking both infection and transmission of Covid - 19 Nasal route has excellent potential for vaccination due to the organized immune systems of nasal mucosa. High compliance Able to meet global demand.

6. On December 2022, the Governmentt of India approved the intranasal vaccine for inclusion in the vaccination programme as a booster dose for those above 18 years of age. Developed by Bharat Biotech , India